-
Taxonomy & unit
-
ratio: %
-
Description
-
Return on equity can be defined as the amount of net income returned as a percentage of shareholders equity. Return on equity measures a corporation's profitability by revealing how much profit a company generates with the money shareholders have invested.
-
Summary
-
X4 Pharmaceuticals, Inc quarterly/annual Return On Equity history and growth rate from Q3 2018 to Q3 2024.
- X4 Pharmaceuticals, Inc Return On Equity for the quarter ending September 30, 2024 was -32.5 %, a 80.9% increase year-over-year.
- X4 Pharmaceuticals, Inc annual Return On Equity for 2023 was -170 %, a 2.29% increase from 2022.
- X4 Pharmaceuticals, Inc annual Return On Equity for 2022 was -174 %, a 59.7% decline from 2021.
- X4 Pharmaceuticals, Inc annual Return On Equity for 2021 was -109 %, a 69.4% decline from 2020.
Return On Equity, Quarterly (%)
Return On Equity, YoY Quarterly Growth (%)